In conclusion, after validation of commercially available ABCG2 antibodies, we established scoring guidelines for semi-quantitative measurement of ABCG2 in FFPE CRC tissue, based on the clinically used guidelines for HER2 assessment in gastric cancer. The gene discussed is ABCG2; the disease is colorectal carcinoma.